Piscataway, NJ, November 17, 2023–Camber Pharmaceuticals is pleased to announce the addition of Bupropion HCl ER Tablets, USP (SR) to its current portfolio.
Bupropion HCl ER Tablets, USP (SR) are an aminoketone antidepressant, indicated for the treatment of major depressive disorder.
Bupropion HCl ER Tablets, USP (SR) are available in 100 and 150 mg strengths in 60, 100 and 500 count bottles as well as 200 mg in 60 and 100 count bottles.
To find out more about Bupropion HCl ER Tablets, USP (SR) please visit www.camberpharma.com/bupropion
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.
